Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2012, Vol. 17 ›› Issue (2): 195-198.

Previous Articles     Next Articles

Meta analysis on Pule'an for treating benign prostatic hyperplasia

LV Shen1, CAO Ting-wei2   

  1. 1Zhejiang Modern Chinese Medicine and Natural Drug Research Institute,Hangzhou 310052, Zhejiang, China;
    2Tiantai County Cangshan Hospital, Tiantai 317200, Zhejiang, China
  • Received:2011-10-24 Revised:2011-12-13 Online:2012-02-26 Published:2012-03-12

Abstract: AIM: To evaluate the efficacy of Pule'an for treating benign prostatic hyperplasia(BPH).METHODS: The data of randomized controlled trials(RCT) of Chinese studies on Pule'an for the treatment of BPH all over China were retrieved from CNKI, Wanfang Data and VIP. The data were extracted by using designed extraction form. Data were processed by Stata 11.0.RESULTS: Five studies involving 361 men met the inclusion criteria, which were included in the Meta analysis. The baseline of patients' characteristics was comparable in all the studies.CONCLUSION: By comparing the five common criteria, it was found that Pule'an was effective for improving IPSS, Qmax and QOL. More high quality trials with large samples and longer follow-up will be better for understanding the effects of Pule'an in BPH.

Key words: Hyperplasia of prostate gland, Qianliekang, Pule&apos, an, Meta analysis

CLC Number: